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ABSTRACT. In this study, we aimed to compare the protective effects of melatonin and amifostine on radiation-in-
duced oxidative stress. Fifty female Wistar rats (3-4 months old, weighing 200±25 g) were divided into five groups 
(with ten rats each) and treated as follows: control (Cont), radiotherapy alone (RT), radiotherapy + amifostine (RT+A-
MI), radiotherapy + melatonin (RT+MEL), radiotherapy + amifostine + melatonin (RT+AMI+MEL). Rats were irradi-
ated individually with a single dose of 8 Gy and amifostine (200 mg/kg) and melatonin (10 mg/kg) was administered 
to rats 30 minutes before irradiation. At the end of this follow-up period (72 hours) the rats were sacrificed. Spec-
trophotometric Analysis has been performed to kidney tissue samples. As a result of statistical comparison between 
groups after RT, total antioxidant capacity (TAC) decreased, total oxidant status (TOS) and oxidative stress index (OSI) 
increased, although the statistically significant change was only for OSI (p = 0.030). Addition of AMI or MEL to RT 
increased TAC and OSI significantly (p = 0.000), but there was no additive effect for TAC and OSI when both drugs 
were given together (p = 1.000, p = 0.172, respectively). In terms of TOS, statistically significant increasing was only 
for AMI (p = 0.000). There was protective effect when both drugs were given together against on Radiation-Induced 
Renal Oxidative Stress. 
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INTRODUCTION
After exposure to radiation, free radicals occur in cells within milliseconds. The subsequent alter-
ations in intracellular processes following irradiation 
are due to the initial oxidative damage caused by 
these free radicals. The physiological signs of these 
radiation-induced alterations have been suggested to 
contribute to adaptive responses, bystander effects, 
cytotoxicity, radiosensitization, genomic instability, 
inflammation, and fibrosis. While most of the mo-
lecular changes associated with the initial production 
of free radicals at the time of irradiation are known, 
the contribution of metabolic processes to biological 
outcomes following exposure to radiation have been 
identified recently (Spitz, Azzam, Li, & Gius, 2004). 
Superoxide anion (O2
−), hydroxyl radical (OH−), and 
hydrogen peroxide (H2O2) are the reactive oxygen 
species (ROS) that form after the radiolysis of wa-
ter (Kaushal, Chandrashekar, & Juncos, 2019; Zhang 
et al., 2019). There are some protective enzymes in 
cells such as superoxide dismutase, catalase, and glu-
tathione peroxidase that are increased in radiation-in-
duced oxidative stress (Bhosle, Huilgol, & Mishra, 
2005; Musa, Shabeeb, & Alhilfi, 2019). In this con-
text, O2
− can be eliminated by Superoxide dismutases 
(SOD), and Glutathione peroxidase (GSH-Px) is the 
major antioxidant enzyme responsible for hydrogene 
proxide (H2O2) detoxification (Sun, Chen, Li, & Ge, 
1998). Amifostine (WR-2721), as an organic thio-
phosphate, is the only FDA-approved radioprotect-
ant agent used in radiotherapy and capable of ROS 
scavenging (Cakmak, Severcan, Zorlu, & Severcan, 
2016). Melatonin (N-acetyl-5-methoxytryptamine), 
a hormone majorly secreted in the pineal gland, has 
abilities to scavenge free radicals as well as antiox-
idant effects by stimulating antioxidant enzymes 
(Musa, Shabeeb, & Alhilfi, 2019).
In this study, we aimed to compare the protective 
effects of melatonin and amifostine on radiation-in-
duced oxidative stress. No functional endpoints were 
tested.
MATERIALS AND METHODS
Study design and animals
All experiments were conducted adhering to the 
guidelines of the institutional animal ethics com-
mittee (TUHDYEK-2012/18). This work was sup-
ported by the Scientific Research Projects Coordi-
nation Unit of Trakya University (Project Number: 
TUBAP:2012/104). As a result of the power analysis 
performed for the study design, it was planned to re-
cruit 10 rats to each group for %95 reliability. Inclu-
sion cirteria: Weight between 170 g and 230 g, female 
rats, survival after treatment. Exclusion criteria: The 
weight less than 150 g or greater than 280 g, male 
rats, the dead rats after treatment. Fifty female Wistar 
rats, 3-4 months old, weighing 200 ± 25 g, maintained 
under standard temperature and humidity conditions, 
were used in the study. The animals had free access 
to sterile water and food and were housed in a poly-
propylene cage containing sterile paddy husk for bed-
ding throughout the experiment. All animals received 
humane care according to the criteria outlined in the 
“Guide for the Care and Use of Laboratory Animals” 
prepared by the National Academy of Sciences and 
published by the National Institutes of Health. The 
animals were divided into five groups (with ten rats 
each) and treated as follows:
• Group 1: control (Cont);
• Group 2: radiotherapy alone (RT);
• Group 3: radiotherapy + amifostine (RT+AMI);
• Group 4: radiotherapy + melatonin (RT+MEL);
• Group 5: radiotherapy + amifostine + mela-
tonin (RT+AMI+MEL).
Animals in the RT group were treated with 
0.9% saline solution (SS) 30 minutes before irradi-
ation. Amifostine was administered to the rats in 
the RT+AMI and RT+AMI+MEL groups 30 min-
utes before irradiation. Animals in the RT+AMI and 
RT+AMI+MEL groups received amifostine (200 mg/
kg, ER-KIM Ilac, Istanbul, Turkey) by intraperitoneal 
injection before irradiation (Cosar et al., 2012). Mela-
tonin was administered to the rats in the RT+MEL and 
RT+AMI+MEL groups 30 minutes before irradiation. 
Animals in the RT+MEL and RT+AMI+MEL groups 
received melatonin (10 mg/kg, Sigma Chemical Co, 
St. Louis, USA) by intraperitoneal injection before 
irradiation (Sener, Jahovic, Tosun, Atasoy, & Yegen, 
2003). All experimental procedures were performed 
on anesthetized rats. Anesthesia was performed via 
intramuscular ketamine (100 mg/kg, Pfizer Ilac, Is-
tanbul, Turkey) and xylazine (3.9 mg/kg, Interhas 
A.S., Istanbul, Turkey) during irradiation. The fol-
low-up period was 72 hours in all groups. At the end 
of this follow-up period, after all rats were anesthe-
tized, the rats were sacrificed using cervical disloca-
tion method (Cosar et al., 2012). After irradiation, the 
animals were closely monitored until they recovered 
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from anesthesia. No animals died due to irradiation or 
medication.
Irradiation
Rats were anesthetized and fixed on their blocks 
across a blue Styrofoam (Med-Tec, Orange City, IA, 
USA) treatment couch in prone position. RT, RT+A-
MI, RT+MEL and RT+AMI+MEL groups were ir-
radiated individually with a single dose of 8 Gy 
using a 60Co treatment unit (Cirus, cis-Bio Int., Gif-
sur-Yvette, France). Dose rate was 1.15 Gy/min.
Spectrophotometric Analysis
Kidney tissue samples were excised, weighed, 
and immediately stored at −50ºC for later spectro-
photometric analyses. The kidney tissues cleaned 
with 1.15% ice-cold KCl, minced, and then homog-
enized in five volumes (w/v) of the same solution. 
The homogenates were spun at 14000 rpm for 30 
min at +4ºC, and assays were performed on the re-
sultant supernatant. The protein concentration of the 
tissue was measured using the Lowry method (Lowry, 
Rosebrough, Farr, & Randall, 1951). The total anti-
oxidant capacity (TAC) of supernatant fractions was 
evaluated using a novel automated and colorimetric 
measurement method developed by Erel et al. (Erel, 
2004). Hydroxyl radicals, the most potent biological 
radicals, are produced in this method. In the assay, 
the ferrous ion solution present in Reagent 1 is mixed 
with hydrogen peroxide, which is present in Rea-
gent 2. The subsequently produced radicals, such as 
brown-colored dianisidine radical cations produced 
by the hydroxyl radicals, are also potent radicals. Us-
ing this method, the antioxidative effect of the sample 
is measured against the potent-free radical reactions 
initiated by the produced hydroxyl radicals. The assay 
has excellent precision values lower than 3%. TAC 
results are expressed as μmole Trolox equivalent/mg 
protein. The total oxidant status (TOS) of supernatant 
fractions was evaluated using a novel automated and 
colorimetric measurement method developed by Erel 
(Erel, 2005). Oxidants present in the sample oxidize 
the ferrous ion-o-dianisidine complex to ferric ion. 
The oxidation reaction is increased by glycerol mol-
ecules, which are abundantly present in the reaction 
medium. The ferric ion makes a colored complex with 
xylenol orange in an acidic medium. The color inten-
sity, which can be measured spectrophotometrically, 
is related to the total amount of oxidant molecules 
present in the sample. The assay is calibrated with 
hydrogen peroxide, and the results are expressed in 
terms of μmole H2O2 equivalent/mg protein (Ozturk 
et al., 2011). The ratio of TOS to TAC was regard-
ed as the oxidative stress index (OSI). The units for 
kidney tissue TOS and TAC values were converted to 
μmole H2O2 Equiv./gram protein. The kidney tissue 
OSI value was calculated as follows: OSI = ((TOS, 
μmole H2O2 Equiv./gram protein)/(TAC, μmole H2O2 
Equiv./gram protein) × 100) (Aycicek, Erel, & Kocy-
igit, 2005).
Statistical Analysis
All statistical evaluations were made using the 
SPSS 19 package program. One way analysis of vari-
ance and Mann-Whitney U test (post hoc with Bon-
feroni correction) were used to determine differences 
between the groups. All parameters were given as 
mean ± SD. Significance was considered at p <0.05. 
RESULTS
All the animals were included in the analysis. Af-
ter radiotherapy, although TAC decreased, TOS and 
OSI increased, although only the change in OSI was 
statistically significant ( p=0.03). Addition of ami-
fostine or melatonin to radiotherapy increased TAC 
significantly ( p=0.00), but there was no additive ef-
fect for TAC when both drugs were given together. In 
terms of TOS, there was an increase, but this was sta-
tistically significant only for amifostine. Results for 
OSI were similar to TAC results (Table 1 and table 2).
Table 1. Spectrophotometric analysis results
Group
TAC (μmole H2O2 
Equiv./gram protein)
TOS (μmole H2O2 
Equiv./gram protein)
OSI = ((TOC, μmole H2O2 Equiv./gram protein)/
(TAC, μmole H2O2 Equiv./gram protein) × 100)
1 Control 3.58±0.45 0.99±0.34 0.02±0.009
2 RT 2.98±0.67 2.11±0.91 0.07±0.030 A*
3 RT+AMI 4.16±0.21 E*** 6.7±1.53 E*** 0.15±0.030 E***
4 RT+MEL 4.50±0.62 F*** 3.02±1.27 0.07±0.039 
5 RT+AMI+MEL 2.89±0.48 2.92±0.71 0.10±0.30
Data are given as mean±SD. * p< 0.05, ** p<0.01, ***p<0.001. Group Comparisons: A: 1 and 2, B: 1 and 3, C: 1 and 
4, D: 1 and 5, E: 2 and 3, F: 2 and 4, G: 2 and 5. Abbreviations: AMI, Amifostine; MEL, Melathonin; RT, Radiotherapy; 
TAC, Total Antioxidant Capacity; TOS, Total Oxidant Status; OSI, Oxidative Stress Index
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Table 2. The statistical comparison of the groups for TAC, TOS and OSI
Groups 1 2 3 4
TAC
2 .131
3 .147 .000
4 .002 .000 1.000
5 .050 1.000 .000 ,000
TOS
2 .208
3 .000 .000
4 .001 .581 .000
5 .002 .888 .000 1,000
OSI
2 .030
3 .000 .000
4 .029 1.000 .000
5 .000 .172 .001 .178
Abbreviations: AMI, Amifostine; MEL, Melathonin; RT, Radiotherapy; TAC, Total Antioxidant Capacity; TOS, Total 
Oxidant Status; OSI, Oxidative Stress Index , Group 1: control (Cont), Group 2: radiotherapy alone (RT), Group 
3: radiotherapy + amifostine (RT+AMI), Group 4: radiotherapy + melatonin (RT+MEL), Group 5: radiotherapy + 
amifostine + melatonin (RT+AMI+MEL),
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DISCUSSION
The main finding of this study is melatonin and 
amifostine may have some protective effect on radi-
ation-induced renal oxidative stress. Radiation is an 
important inducer of oxidative stress, and chronic ox-
idative stress after total body irradiation is thought to 
be the cause of radiation nephropathy in rats (Ozbek, 
2012). In our study, whole body irradiation of rats 
provoked oxidative stress in the kidney, identified by 
elevated levels of TOS and decreased levels of TAC 
compared to their respective values in control rats. 
The decrease in antioxidants might result from their 
increased utilization to neutralize the excess of free 
radicals, as well as their release to the blood stream 
resulting from radiation-induced cell membrane dam-
age (Saada Helen & Azab Khaled, 2001). In addition, 
protein oxidation may contribute to the partial inacti-
vation of enzymes (Kregel & Zhang, 2007).
The major enzymatic antioxidants are SOD, cat-
alase, and GSH-Px. SOD is generally thought to act 
as a bulk scavenger of superoxide radicals. H2O2 that 
is produced by the action of SOD or the action of ox-
idases, such as xanthine oxidase, is reduced to water 
by catalase and GSH-Px. Catalase exists as a tetram-
er composed of 4 identical monomers, each of which 
contains a heme group at the active site. Degradation 
of H2O2 is accomplished via catalase. Catalase also 
binds NADPH as a reducing equivalent to prevent ox-
idative inactivation of the enzyme by H2O2 as it is re-
duced to water (Kirkman, Rolfo, Ferraris, & Gaetani, 
1999; Zelko, Mariani, & Folz, 2002). Enzymes in the 
redox cycle responsible for the reduction of H2O2 and 
lipid hydroperoxides (generated as a result of mem-
brane lipid peroxidation) include GSH-Px. GSH-Px 
reduces H2O2 and lipid peroxides to their correspond-
ing alcohols (Flohe, Gunzler, & Schock, 1973).
The role of melatonin as a protector against ioniz-
ing radiation has been investigated in different studies. 
These results suggest that the radioprotective effect of 
melatonin is not species-specific and acts in a simi-
lar way in different biological systems (Blickenstaff, 
Brandstadter, Reddy, & Witt, 1994; Vijayalaxmi, 
Reiter, & Meltz, 1995; Vijayalaxmi, Reiter, Sewery-
nek, et al., 1995). Melatonin is a remarkably efficient 
oxygen radical scavenger. In vitro, melatonin is five-
fold better at neutralizing hydroxyl radicals than glu-
tathione and twofold more effective at inactivating 
peroxyl radicals than vitamin E (Baldwin & Barrett, 
1998; Haghi-Aminjan et al., 2018). Also, melatonin’s 
protective effects in some subcellular compartments 
may be due to its indirect antioxidative actions such 
as stimulation of enzymes that either promote the 
synthesis of other antioxidants or metabolize reactive 
species to non-radical products (El-Sokkary, Omar, 
Hassanein, Cuzzocrea, & Reiter, 2002; Hara et al., 
1997; Kotler, Rodriguez, Sainz, Antolin, & Menen-
dez-Pelaez, 1998). Histopathological studies have 
shown that melatonin has a protective effect against 
radiation-induced nephrotoxicity (Kucuktulu et al., 
2012; Ozen et al., 2013).
Amifostine is an organic thiophosphate ester prod-
rug and must be activated by alkaline phosphatase 
to be converted into an active sulfhydryl compound 
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(Kaldir et al., 2008; Levi et al., 2002). It has been 
shown that amifostine can ameliorate functional renal 
damage in rat kidneys (Caloglu et al., 2009; Rolle-
man et al., 2007). Amifostine is a broad-spectrum cy-
toprotective agent and selectively protects all normal 
tissues without decreasing the response of neoplastic 
tissues to the cytotoxic effects of radiation therapy. 
Normal tissues have higher alkaline phosphatase ac-
tivity in the plasma membrane, higher interstitial pH, 
and better vascularity when compared with tumor 
cells (Hensley et al., 2009). It has been known from 
previous study that the sublethal dose of whole body 
ionizing radiation had a protective effect against ami-
fostine damage to brain tissue (Cakmak et al., 2009). 
The protective effect of amifostine against renal ox-
idative stress has been shown (Jacevic et al., 2018; 
Stankiewicz & Skrzydlewska, 2003). 
In our study, addition of amifostine or melatonin to 
radiotherapy increased TAC significantly. There was 
no statistically significant difference in TAC between 
amifostine and melatonin administration, and there 
was no additive effect on TAC and TOS when both 
drugs were given together. In terms of TOS, there was 
an increase, but this was statistically significant only 
for amifostine administration. An interesting finding 
of this study is that mean OSI levels in Group 3 al-
most two-fold higher in Group 2. This may be due to 
an increase in total oxidant capacity in kidney tissue. 
And finally, there was no significant protective effect 
of both drugs on OSI.
CONCLUSIONS
In conclusion, we suggest that melatonin and am-
ifostine have some protective effects on radiation-in-
duced renal oxidative stress.. For this reason, we think 
that this study is very important for the literature. Au-
thors should discuss the results and how they can be 
interpreted in perspective of previous studies and of 
the working hypotheses. The findings and their im-
plications should be discussed in the broadest context 
possible. Future research directions may also be high-
lighted. Strengths and limitations of the study should 
be discussed as well.
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